Skip to content

A study on the maintenance treatment of accelerated sequential TBS therapy for treatment-resistant depression and its mechanism exploration

A study on the maintenance treatment of accelerated sequential TBS therapy for treatment-resistant depression and its mechanism exploration

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096616
Enrollment
Unknown
Registered
2025-01-26
Start date
2025-01-27
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive symptoms

Interventions

Sequential TBS maintenance verum stimulation group:Sequential active TBS
Sequential TBS maintenance sham stimulation group:Sequential sham TBS

Sponsors

Affiliated Kangning Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-65 years; 2.Patients experiencing a non-psychotic major depressive episode as defined the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and measuring a moderate to severe level of treatment resistance using the Maudsley Staging (MSM). 3.Patients who have undergone at least two antidepressant medications with different mechanisms of action, at adequate doses and duration, with poor efficacy no response. 4.Total score on the 24-item Hamilton Rating Scale for Depression (HAMD-24) >20; 5.Patients who can complete the first 5-day accelerated sequential TBS treatment and achieve a 50% response rate; 6. Right-handed; 7.Normal physical examination, medical history, vital signs, routine blood, urine, and stool tests, liver and kidney function, electrolytes, electrocardiogram, electroencephalogram; 8. Fully understanding the safety of Transcranial Magnetic Stimulation (TMS), willing to cooperate with the treatment, and the informed consent form with both the patient and their family.

Exclusion criteria

Exclusion criteria: 1.Age 60 years; 2. History of severe physical illness and depression caused by other psycho substances and non-dependent substances; 3.Patients with metal or electronic devices in their bodies, such as intracranial metal foreign bodies, cochlear implants pacemakers, and metal stents; 4. Risk of epileptic seizures, history of cerebrocranial diseases, head injuries, alcoholism, abnormal, MRI evidence of abnormal brain structure, or family history of epilepsy; 5. Presence of psychotic symptoms requiring concurrent antipsychotic drugs; 6.ECT treatment within 2 months before enrollment; 7. Refusal to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Depression detection;

Secondary

MeasureTime frame
magnetic resonance imaging;Near Infrared Imaging;Resting state/task state Electroencephalogram;Transcranial magnetoencephalography;Transcranial magneto-myography;Paired pulse stimulation;cognitive assessment;Suicide assessment;Anxiety testing;Sleep quality assessment;

Countries

China

Contacts

Public ContactCHANG YU

Affiliated Kangning Hospital of Ningbo University

272450699@qq.com+86 158 8810 7922

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026